Juntendo University · Graduate School of Medicine / Faculty of Medicine · 助教

Research keywordsParkinson disease・alpha-synuclein biomarkers・levodopa metabolism・multiple system atrophy・status epilepticus・machine learning prediction・Brivaracetam therapy・drooling severity

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• First-year Experience with Brivaracetam in Japan: Real-world Data from Juntendo Epilepsy Center.2026
• Impact of catechol-O-methyltransferase inhibition on plasma homocysteine levels in levodopa-treated Parkinson's disease.2026
• Aphasic status epilepticus caused by nonketotic hyperglycemia without hyperosmolality.2026
• Identification of perception gaps between physicians and patients with neurological diseases and the prediction of these gaps using machine learning.2026

• アフェレシス療法を用いた多系統萎縮症の病態解明2026
• αシヌクレイン-不飽和脂肪酸結合阻害を基盤とした新規パントテン酸キナーゼ関連神経変性症の根治治療シーズ開発2025
• パーキンソン病病態と血液脳関門の関連の検討2022
• 血清αシヌクレインシードに着眼したシヌクレイノパチーの病態解明と新規治療法の開発2021

• Official profile